SteelPeak Wealth’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
DLA
OIAM
YIH
CNB
COPPSERS
LAI
YCM
1WA
SOADOR
SteelPeak Wealth's MRNA Position: Q2 2026 in Review
SteelPeak Wealth opened a new position in Moderna (MRNA) in Q2 2026: 3,270 shares worth $229K. The stake represents 0.01% of the portfolio and ranks #584 among its holdings. This is a return to the name: SteelPeak Wealth previously reported a position in MRNA as recently as Q3 2024.
SteelPeak Wealth first reported a position in MRNA in Q4 2020 and has held it in 17 quarters since. The position peaked at $8.59M in Q3 2021. 111 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- SteelPeak Wealth held 3,270 shares of Moderna worth $229K as of Q2 2026.
- Moderna was a new SteelPeak Wealth position in Q2 2026.
- Moderna made up 0.01% of SteelPeak Wealth's portfolio in Q2 2026, its #584 holding.
- SteelPeak Wealth first reported a position in Moderna in Q4 2020 and has held it in 17 quarters since.
- SteelPeak Wealth's Moderna position peaked at $8.59M in Q3 2021.
- 111 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.